So the final cohort of patients was 76, one more added in a quarter and a bit. If they have had date for 75/76 trial patients, then you would think they had something statistical to share with potential pharmas? Surely the last patient would not make that much difference? So is the question.....Just what on earth have you been waiting on, why the delay in sharing, considering interim results were out in November 2921?
SPL Price at posting:
48.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)